admin
Photo Caption (L-R)– Dr. (Prof) Vijay Patil (Founder, SunAct Cancer Institute), Dr. Suresh Advani, Padma Shri, Padma Bhushan (Chairman, Smita Memorial Hospital & Research Centre) & Dr. Ashay Karpe (Cofounder, SunAct Cancer Institute) at the signing of the strategic collaboration between SunAct and Smita Memorial Hospital & Research Centre on Wednesday, March 12, 2025
India
healthysoch
Mumbai/Thane/New Delhi, March 15, 2025:
SunAct Cancer Institute is proud to announce a strategic collaboration with Smita Memorial Hospital & Research Centre in Thodupuzha, Kerala (approximately 60 km from Kochi), to transform cancer treatment in India. This partnership will establish a Centre for Advanced Cancer Therapeutics at Smita Memorial Hospital, significantly enhancing cancer care services by integrating some of the most advanced and innovative therapies available today. Strengthening this initiative is Dr. Suresh H. Advani, widely regarded as the Father of Medical Oncology in India. A recipient of the Padma Shri (2002) and Padma Bhushan (2012), Dr. Advani’s expertise and leadership will be instrumental in advancing cancer treatment through this collaboration.
SunAct Cancer Institute is dedicated to pushing the boundaries of cancer care by integrating research-driven innovation with patient-centric treatment. With this collaboration, SunAct aims to introduce cutting-edge therapies, expand access to precision medicine, and enhance clinical outcomes. By leveraging Smita Memorial Hospital’s world-class infrastructure and Dr. Advani’s unparalleled expertise, this initiative is set to redefine the standard of oncology care in India.
Dr. Advani, Chairman, Smita Memorial Hospital & Research Centre, said, “This collaboration marks a defining moment in India’s fight against cancer. By bringing together cutting-edge therapies and world-class expertise, we are creating a healthcare ecosystem where patients have access to the best possible treatments without needing to travel abroad. Our shared vision is to make breakthrough cancer care more accessible and affordable.”
“SunAct Cancer Institute was founded with the mission of bridging the gap in high-quality cancer treatment through innovation and research-driven care. This partnership with Smita Memorial Hospital, coupled with the expertise of Dr. Advani, will allow us to introduce transformative therapies like CAR-T cell treatment for solid tumors—something unprecedented in India. We are setting a new benchmark in oncology,” said Dr. (Prof.) Vijay Patil, Founder of SunAct Cancer Institute.
A key milestone of this collaboration is the introduction of CAR T-cell therapy for solid tumors, a revolutionary treatment currently unavailable elsewhere in India. In addition, the initiative will focus on TCR, TIL, Gamma Delta, Gene Therapy, and Pediatric Oncology Services, ensuring comprehensive, state-of-the-art care for patients. The partnership will also strengthen Bone Marrow Transplant (BMT) programs and expand access to cutting-edge clinical trials, reinforcing a shared commitment to world-class cancer care.
HealthySoch
